Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany

Heinrich L, Birkner T, Abraham S, Gerdes S, Honstein T, Müller S, Augustin M, Harder I, Schaefer T, Pinter A, Bong A, Ramaker-Brunke J, Biedermann T, Sticherling M, Gorriahn-Maiterth H, Schäkel K, Schwarz B, Quist S, Asefi M, Adler N, Stahl M, Schulz-Kiesow M, Schenck F, Werfel T, Weidinger S, Heratizadeh A, Schmitt J (2025)

Publication Type: Journal article

Publication year: 2025

Journal

Skin Health and Disease Wiley

Book Volume: 5

Pages Range: 490-492

Journal Issue: 6

DOI: 10.1093/skinhd/vzaf075

Authors with CRIS profile

Michael Sticherling Professur für Entzündungsdermatologie

Involved external institutions

Universitätsklinikum Heidelberg DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Helix Mainz GmbH & Co. KG DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Hautarztpraxis Dr. Bong DE Germany (DE) Technische Universität München (TUM) DE Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) DE Germany (DE)

How to cite

APA:

Heinrich, L., Birkner, T., Abraham, S., Gerdes, S., Honstein, T., Müller, S.,... Schmitt, J. (2025). Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany. Skin Health and Disease, 5(6), 490-492. https://doi.org/10.1093/skinhd/vzaf075

MLA:

Heinrich, Luise, et al. "Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany." Skin Health and Disease 5.6 (2025): 490-492.

BibTeX: Download